The role of vFLIP in the survival of PEL cells may be linked to its ability to activate the NF-κB pathway, because a small molecule NF-κB inhibitor induces apoptosis in PEL cell lines [222]. The gene discussed is NFKB1; the disease is primary effusion lymphoma.